ADAPTIMMUNE THERAPEUTICS PLC Investing Cash Flow
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Investing Cash Flow of $59.64 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $18.49M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $41.15M.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $8.17M, a 88.02% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was -$66.02M, a 215.20% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for fiscal 2024 was -$58.95M, a 133.39% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for fiscal 2023 was $176.54M, a 98.05% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for fiscal 2022 was $89.14M, a 17.59% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC net cash provided by (used in) investing activities for fiscal 2021 was $75.80M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $18.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $59.64M 10-Q · filed 2025-08-13 | $67.81M derived: sum of 3 quarters · filed 2025-08-13 | $1.79M derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $41.15M 10-Q · filed 2025-05-13 | $49.32M derived: sum of 2 quarters · filed 2025-05-13 | -$16.70M derived: sum of 3 quarters · filed 2025-05-13 | -$17.44M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-12-31 | $8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$57.85M derived: sum of 2 quarters · filed 2025-03-24 | -$58.59M derived: sum of 3 quarters · filed 2025-08-13 | -$58.95M 10-K · filed 2025-03-24 |
| 2024-09-30 | -$66.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$66.76M derived: sum of 2 quarters · filed 2025-08-13 | -$67.12M 10-Q · filed 2024-11-13 | $1.08M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-06-30 | -$743.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.10M 10-Q · filed 2025-08-13 | $67.10M derived: sum of 3 quarters · filed 2025-08-13 | $124.40M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$358.00K 10-Q · filed 2025-05-13 | $67.84M derived: sum of 2 quarters · filed 2025-05-13 | $125.14M derived: sum of 3 quarters · filed 2025-05-13 | $127.84M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $68.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $125.50M derived: sum of 2 quarters · filed 2025-03-24 | $128.20M derived: sum of 3 quarters · filed 2025-03-24 | $176.54M 10-K · filed 2025-03-24 |
| 2023-09-30 | $57.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $60.00M derived: sum of 2 quarters · filed 2024-11-13 | $108.34M 10-Q · filed 2024-11-13 | $129.29M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $51.03M 10-Q · filed 2024-08-12 | $71.99M derived: sum of 3 quarters · filed 2025-03-24 | $100.84M derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-03-31 | $48.34M 10-Q · filed 2024-05-15 | $69.29M derived: sum of 2 quarters · filed 2025-03-24 | $98.14M derived: sum of 3 quarters · filed 2025-03-24 | $142.25M derived: sum of 4 quarters · filed 2025-03-24 |
| 2022-12-31 | $20.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $49.80M derived: sum of 2 quarters · filed 2025-03-24 | $93.91M derived: sum of 3 quarters · filed 2025-03-24 | $89.14M 10-K · filed 2025-03-24 |
| 2022-09-30 | $28.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $72.96M derived: sum of 2 quarters · filed 2023-11-08 | $68.19M 10-Q · filed 2023-11-08 | $39.69M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $44.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $39.33M 10-Q · filed 2023-08-09 | $10.84M derived: sum of 3 quarters · filed 2024-03-06 | $45.69M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | -$4.78M 10-Q · filed 2023-05-12 | -$33.27M derived: sum of 2 quarters · filed 2024-03-06 | $1.58M derived: sum of 3 quarters · filed 2024-03-06 | $49.26M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | -$28.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $6.36M derived: sum of 2 quarters · filed 2024-03-06 | $54.04M derived: sum of 3 quarters · filed 2024-03-06 | $75.80M 10-K · filed 2024-03-06 |
| 2021-09-30 | $34.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $82.53M derived: sum of 2 quarters · filed 2022-11-08 | $104.29M 10-Q · filed 2022-11-08 | $111.90M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $47.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $69.44M 10-Q · filed 2022-08-04 | $77.05M derived: sum of 3 quarters · filed 2023-03-06 | $49.47M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $21.76M 10-Q · filed 2022-05-09 | $29.37M derived: sum of 2 quarters · filed 2023-03-06 | $1.79M derived: sum of 3 quarters · filed 2023-03-06 | -$185.22M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$19.97M derived: sum of 2 quarters · filed 2023-03-06 | -$206.98M derived: sum of 3 quarters · filed 2023-03-06 | -$278.92M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$27.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$214.59M derived: sum of 2 quarters · filed 2021-11-04 | -$286.53M 10-Q · filed 2021-11-04 | -$262.85M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-06-30 | -$187.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$258.95M 10-Q · filed 2021-08-09 | -$235.27M derived: sum of 3 quarters · filed 2022-03-14 | -$200.22M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | -$71.95M 10-Q · filed 2021-05-06 | -$48.26M derived: sum of 2 quarters · filed 2022-03-14 | -$13.22M derived: sum of 3 quarters · filed 2022-03-14 | $5.34M derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | $23.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $58.73M derived: sum of 2 quarters · filed 2022-03-14 | $77.29M derived: sum of 3 quarters · filed 2022-03-14 | $94.94M 10-K · filed 2022-03-14 |
| 2019-09-30 | $35.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $53.61M derived: sum of 2 quarters · filed 2020-11-05 | $71.26M 10-Q · filed 2020-11-05 | $18.85M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $18.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $36.22M 10-Q · filed 2020-08-06 | -$16.19M derived: sum of 3 quarters · filed 2021-02-25 | -$15.25M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $17.66M 10-Q · filed 2020-05-14 | -$34.76M derived: sum of 2 quarters · filed 2021-02-25 | -$33.81M derived: sum of 3 quarters · filed 2021-02-25 | -$13.44M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$52.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$51.47M derived: sum of 2 quarters · filed 2021-02-25 | -$31.10M derived: sum of 3 quarters · filed 2021-02-25 | -$17.46M 10-K · filed 2021-02-25 |
| 2018-09-30 | $942.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $21.32M derived: sum of 2 quarters · filed 2019-11-06 | $34.95M 10-Q · filed 2019-11-06 | -$5.06M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $20.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $34.01M 10-Q · filed 2019-08-01 | -$6.00M derived: sum of 3 quarters · filed 2019-08-01 | $3.75M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $13.64M 10-Q · filed 2019-05-06 | -$26.37M derived: sum of 2 quarters · filed 2019-05-06 | -$16.62M derived: sum of 3 quarters · filed 2019-05-06 | -$89.81M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | -$40.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$30.26M derived: sum of 2 quarters · filed 2019-02-27 | -$103.44M derived: sum of 3 quarters · filed 2019-02-27 | -$126.08M 10-K · filed 2019-02-27 |
| 2017-09-30 | $9.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$63.43M derived: sum of 2 quarters · filed 2018-11-06 | -$86.07M 10-Q · filed 2018-11-06 | -$69.11M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$73.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$95.82M 10-Q · filed 2018-08-02 | -$78.86M derived: sum of 3 quarters · filed 2019-02-27 | -$73.12M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$22.64M 10-Q · filed 2018-05-09 | -$5.68M derived: sum of 2 quarters · filed 2019-02-27 | $65.00K derived: sum of 3 quarters · filed 2019-02-27 | |
| 2016-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $22.70M derived: sum of 2 quarters · filed 2019-02-27 | $17.75M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $796.00K 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$4.95M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | -$9.84M 10-K · filed 2018-03-15 | |||
| 2015-06-30 | -$58.84M 10-K · filed 2018-03-15 |